Press releases 2012
Scientists discover new diagnostic markers for Kawasaki disease
HEIDELBERG, 20 December 2012 – Researchers have discovered proteins in human urine that offer new opportunities for the diagnosis, study and maybe even the treatment of Kawasaki disease.
Cancer stem cells isolated from kidney tumours
HEIDELBERG, 13 December 2012 – Scientists have isolated cancer stem cells that lead to the growth of Wilms' tumours, a type of cancer typically found in the kidneys of young children.
Ten researchers receive EMBO Installation Grants
HEIDELBERG, 12 December 2012 — Ten life science researchers will receive the 2012 EMBO Installation Grants. The grants will assist the scientists to relocate and set up their research groups in the Czech Republic, Estonia, Poland, Portugal, and Turkey.
EMBO, EMBC and the National Science Council of Taiwan sign cooperation agreement
HEIDELBERG, 29 November 2012 – New ways of global scientific interaction have been created following a cooperation agreement between EMBO, its inter-governmental funding body, the European Molecular Biology Conference (EMBC), and the National Science Council of Taiwan (NSC). The agreement will allow Taiwanese scientists to participate in EMBO training programmes and activities. It also means that EMBO Courses & Workshops can take place at Taiwanese research institutes.
Engineered bacteria can make the ultimate sacrifice
HEIDELBERG, 20 November 2012 – Scientists have engineered bacteria that are capable of sacrificing themselves for the good of the bacterial population. These altruistically inclined bacteria, which are described online in the journal Molecular Systems Biology, can be used to demonstrate the conditions where programmed cell death becomes a distinct advantage for the survival of the bacterial population.
22 young group leaders recognized as EMBO Young Investigators
HEIDELBERG, 14 NOVEMBER 2012 – EMBO announced today the selection of 22 young researchers as EMBO Young Investigators.
No evidence for 30-nm chromatin fibres in the mouse genome
HEIDELBERG, 4 October 2012 – Scientists in Canada and the United States have used three-dimensional imaging techniques to settle a long-standing debate about how DNA and structural proteins are packaged into chromatin fibres. The researchers, whose findings are published in EMBO reports, reveal that the mouse genome consists of 10-nm chromatin fibres but did not find evidence for the wider 30-nm fibres that were previously thought to be important components of the DNA architecture.
Brain neurons and diet influence onset of obesity and diabetes in mice
HEIDELBERG, 18 September 2012 – The absence of a specific type of neuron in the brain can leadtoobesity and diabetes in mice report researchers in The EMBOJournal. The outcome, however, depends on the type of diet that the animals are fed.
Scientists reveal how natural antibiotic kills tuberculosis bacterium
HEIDELBERG, 17 September 2012 – A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown how pyridomycin, a natural antibiotic produced by the bacterium Dactylosporangium fulvum, works. This promising drug candidate is active against many of the drug-resistant types of the tuberculosis bacterium that no longer respond to treatment with the front-line drug isoniazid.
Countdown to The EMBO Meeting 2012
HEIDELBERG, 10 September 2012 – More than 100 leading researchers from across the life sciences will speak at The EMBO Meeting 2012, the fourth annual life science conference organized by EMBO, which starts on September 22 in Nice, France. The conference attracts more than 1,200 participants from Europe and worldwide. Together with keynote speeches, special lectures and twenty concurrent sessions, the lineup represents a vast selection of the latest exciting developments from across the life sciences.
Anchoring proteins influence glucose metabolism and insulin release
HEIDELBERG, 3 September 2012 – Scientists from the United States and Sweden have discovered a new control point that could be important as a drug target for the treatment of diabetes and other metabolic diseases. A-kinase anchoring proteins or AKAPs are known to influence the spatial distribution of kinases within the cell, crucial enzymes that control important molecular events related to the regulation of glucose levels in the blood. In a new study published in The EMBO Journal, the team of researchers led by Simon Hinke and John Scott reveal for the first time that AKAPs influence the levels of glucose in the body by coordinating the spatial positioning of phosphatases, naturally occurring enzymes that counteract the effects of kinase enzymes.
Fragile X and Down syndromes share signalling pathway for intellectual disability
HEIDELBERG, 3 August 2012 – Intellectual disability due to Fragile X and Down syndromes involves similar molecular pathways report researchers in The EMBO Journal. The two disorders share disturbances in the molecular events that regulate the way nerve cells develop dendritic spines, the small extensions found on the surface of nerve cells that are crucial for communication in the brain.
Computational analysis identifies drugs to treat drug-resistant breast cancer
HEIDELBERG, 31 July 2012 – Researchers have used computational analysis to identify a new Achilles heel for the treatment of drug-resistant breast cancer. The results, which are published in Molecular Systems Biology, reveal that the disruption of glucose metabolism is an effective therapeutic strategy for the treatment of tumours that have acquired resistance to front-line cancer drugs such as Lapatinib.
The EMBO Meeting 2012 is coming to Nice
HEIDELBERG, 16 July 2012 – What determines the rate of ageing and how can we live longer? How do cells grow and divide? What new species have been recently discovered in the depths of the ocean? These are some of the questions scientists will attempt to answer at The EMBO Meeting to be held in Nice, France, on 22-25 September.
EMBO Gold Medal 2012 awarded to Jiří Friml
Heidelberg, 27 June 2012 – EMBO today announced Jiří Friml of the Department of Plant Systems Biology, VIB and Ghent University, Belgium and Central European Institute of Technology, University Brno, Czech Republic as the winner of the 2012 EMBO Gold Medal.
Naturally occurring protein has a role in chronic pain
HEIDELBERG, 12 June 2012 – Researchers in France and Sweden have discovered how one of the body's own proteins is involved in generating chronic pain in rats. The results, which also suggest therapeutic interventions to alleviate long-lasting pain, are reported in The EMBO Journal.
Special issue of The EMBO Journal celebrates 30 years of Wnt research
HEIDELBERG, 22 May 2012 – The impact and influence of thirty years of research into the Wnt/beta-catenin signaling pathway are highlighted in a special issue of The EMBO Journal. “Three decades of Wnt signalling” summarizes many of the crucial scientific developments that have taken place since the discovery of the first mammalian Wnt gene in 1982. The reviews also describe many of the crucial research findings that have established the pathway as one of the fundamental signal transduction mechanisms in development and disease.
Telomerase gene therapy slows ageing, improves health in mice
HEIDELBERG, 15 May 2012 – Gene therapy allows older mice to live longer, healthier lives report researchers in a new study published in EMBO Molecular Medicine. Mice that received a single gene-therapy treatment to deliver telomerase to different cells in the body showed drastic improvements in health, fitness and longevity. Telomerase is an enzyme that helps to maintain the physical integrity of the ends of chromosomes.
EMBO welcomes 55 leading life scientists as members
Heidelberg, Germany, 9 May 2012 – Fifty-five life scientists from Europe and around the world were today recognised by EMBO for their excellence in research. Forty-eight of the researchers are from Europe and neighbouring countries while seven scientists from Argentina, Australia, South Korea and the United States join as Associate Members. In total, EMBO membership now comprises almost 1,550 life scientists in the international scientific community.
Protein signal is crucial for accurate control of insect size
HEIDELBERG, 4 May 2012 – Two independent groups of researchers have identified a hormone that is responsible for keeping the growth and development of insects on track. The results, which are reported in the journal Science, suggest that Dilp8 provides an important signal to slow body growth and delay insect development. This braking effect is an essential part of normal development since it allows sufficient time for tissues to form and the correct body size, proportions and symmetry to be achieved.
TARA OCEANS completes 60 000-mile journey to map marine biodiversity
HEIDELBERG, 27 March 2012 – The two-and-a-half-year TARA OCEANS expedition finishes on 31 March when the ship and crew reach Lorient, France. The arrival completes a journey of 60 000 miles across all the world’s major oceans to sample and investigate microorganisms in the largest ecosystem on the planet, reports Eric Karsenti in an editorial published today in Molecular Systems Biology.
Antibiotic treatment increases the severity of asthma in young mice
Heidelberg, 16 March 2012 – Treatment with the antibiotic vancomycin increases the severity of allergic asthma in young mice, researchers in Canada have revealed in a new study published in EMBO reports. The results are consistent with the “hygiene hypothesis” that links the loss of beneficial bacteria in the community of microorganisms in the gut, collectively known as the microbiota, to the onset of asthma.
EMBO Molecular Medicine goes Open Access
Heidelberg, 7 March 2012 – EMBO and Wiley-Blackwell today announced that EMBO Molecular Medicine is a fully Open Access journal with immediate effect. EMBO Molecular Medicine is one of the highest cited journals in the biomedical sciences to have converted from a subscription-based model to Open Access.
Susan M. Gasser to receive the 2012 FEBS/EMBO Women in Science Award
Swiss biologist recognized for her research on chromatin biology and epigenetics
Heidelberg, 15 February 2012 – The European Molecular Biology Organization (EMBO) and the Federation of European Biochemical Societies (FEBS) announce Susan Gasser, director of the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, as the winner of the 2012 FEBS/EMBO Women in Science Award. Professor Gasser has been recognized for her outstanding scientific research on genome stability and epigenetics and her commitment to mentoring women pursuing a career in science.
T. + 49 160 9019 3839